FDA/EC mutual recognition agreement
This article was originally published in The Tan Sheet
Executive Summary
Public meeting will be held Dec. 8 to discuss implementation of the Mutual Recognition Agreement Pharmaceutical Good Manufacturing Practices Annex between the U.S. and the European Community. The meeting will take place at FDA headquarters, 5630 Fishers Lane, Rockville, Md., from 9 a.m. to 1 p.m